Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Men with moderate hair loss had the best spatial thinking, and long-term DHT might affect cognition.

New treatments for male hypogonadism are effective and should be personalized.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

DHT, a testosterone byproduct, causes male pattern baldness.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Suppressing certain hormones might help prevent prostate cancer.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

The study created a new method to test drugs that affect hormone processing in skin.

The procedure accurately measures 5-alpha-dihydrotestosterone in blood, useful for standard tests.

Integrating best practices for steroid users in Swiss primary care is feasible and beneficial, but doping laws need change.

Certain gene variations increase male hair loss risk, influenced by hormone levels.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Finasteride doesn't affect bone density in male rats.